EyePoint Pharmaceuticals | 4:持股變動聲明-董事 GUYER DAVID R
EyePoint Pharmaceuticals | 4:持股變動聲明-高管 Duker Jay S.
EyePoint Pharmaceuticals | 4:持股變動聲明-高管 Lurker Nancy
EyePoint Pharmaceuticals | 4:持股變動聲明-董事 Zaderej Karen L.
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | 4:持股變動聲明-董事 ADAMIS ANTHONY P
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | 4:持股變動聲明-董事 GUYER DAVID R
EyePoint Pharmaceuticals | 4:持股變動聲明-高管 Elston George
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | 4:持股變動聲明-董事 GUYER DAVID R
EyePoint Pharmaceuticals | 144:擬議出售證券
EyePoint Pharmaceuticals | 10-Q:季度報表
EyePoint Pharmaceuticals | 4:持股變動聲明-股東 Cormorant Asset Management, LP
EyePoint Pharmaceuticals | 8-K:EyePoint Pharmicals公佈2024年第一季度財務業績並重點介紹最近的公司發展
EyePoint Pharmaceuticals | 8-K:重大事件
EyePoint Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Adage Capital Management, L.P.(9.90%),Robert Atchinson(9.90%)等
EyePoint Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Adage Capital Management, L.P.(10.35%),Robert Atchinson(10.35%)等
EyePoint Pharmaceuticals | DEFA14A:其他
EyePoint Pharmaceuticals | DEF 14A:股東委託書決議
暫無數據